VEGFA and idiopathic pulmonary fibrosis: Clinically, isoform-selective interventions (e.g., neutralization of VEGF-A165a while preserving VEGF-A165b) or compartment-targeted delivery strategies (e.g., inhalable biologics) may offer precise therapeutic approaches by balancing the opposing actions of VEGFA in IPF.